About this trial
The objective of the study is to use neurological techniques to obtain quantitative measurements of nervous system control of skeletal muscle activity in adults aged 60-85 who are either long-term resistance exercisers or who are untrained.
Eligibility criteria
Qualifiers
Participant must have a BMI between 18.5 and 38
Participant be aged between 60 and 85
Regularly exercises at least 5 days a week a minimum of 30 minutes per day.
Engages in less than 2 days of exercise less than 30 minutes each day.
Disqualifiers
Surgical History - Gastric surgery, pacemaker placement, weight loss surgery, metabolic and obstetric surgery.
Smokers will be excluded from the study.
Medications: Insulins, common diabetic drugs, anti-hyperglycemic drugs, beta blockers cardiac selective, beta-blockers noncardiac selective, oral steroids, opioids anti-depressants, and hormones
Conidiations and Diagnosis: Disorder of coronary artery, hepatic failure, gastroparesis, disorder of the adrenal gland, drug related disorders, substance abuse, malignant neoplastic disease, psychotic disorders, disorder of skeletal muscle, finding of brain, chronic kidney disease, renal failure syndrome, disorder of pulmonary circulation, cerebrovascular disease, neuro developmental disorder, disorder of immune function, disorder of central nervous system.
Trial design
Treatments tested in this trial
- Neuromuscular Test
- DEXA
- Mixed Meal Tolerance Test
- Strength Test
Treatment groups
Sponsors and collaborators
Mayo Clinic
Lead sponsor
National Institute on Aging (NIA)
Collaborator